The field of diabetes treatment is undergoing a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide have gained prominence as potential game-changers. This https://ihannakgmo571740.blog2freedom.com/39098584/new-glp-1-receptor-agonists-retatrutide-and-trizepatide